Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion type Assertion NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_head.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion description "[Further, the study indicates that combination therapy with miR-24-2 along with an anticancer drug such as cisplatin could provide a new avenue in cancer therapy for patients with tumors otherwise resistant to drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_provenance.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion evidence source_evidence_literature NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_provenance.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion SIO_000772 21463514 NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_provenance.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion wasDerivedFrom befree-20150227 NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_provenance.
- NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_assertion wasGeneratedBy ECO_0000203 NP999315.RAQEJBNQH9iTe6qQakXVk174KxONcxKpA_uhZibACnZT0130_provenance.